首页> 美国政府科技报告 >Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Evidence Report/Technology Assessment Number 185
【24h】

Diagnosis and Management of Ductal Carcinoma in Situ (DCIS). Evidence Report/Technology Assessment Number 185

机译:乳腺导管原位癌(DCIs)的诊断和治疗。证据报告/技术评估编号185

获取原文

摘要

Objectives: Systematic synthesis of the published evidence about incidence, risk factors, and management options for women with ductal carcinoma in situ (DCIS) of the breast. Data Sources: Original epidemiologic studies were sought from several databases to identity articles published in English between 1970 and January 31, 2009. Review Methods: Incidence of DCIS in the general population and among women at greater risk of breast cancer and patient outcomes after diagnostic magnetic resonance imaging (MRI) or sentinel lymph node biopsy (SLNB) were abstracted into the developed standardized form. Patient outcomes after breast conserving surgery with or without adjuvant radio or chemotherapy or after mastectomy were compared from randomized controlled clinical trials (RCTs) and observational studies.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号